- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有1家主力机构披露2025-12-31报告期持股数据，持仓量总计21.53万股，占流通A股0.03%
- 波段诊断：
-
技术面诊股
诊断结果：4.7技术面打败了12%的股票
技术面评分前10的股票
近期的平均成本为6.17元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为6.17元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.17","date":1774253106,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑输行业平均水平。
[{"date":"2026.03.24","stock":"5.52","trade":null,"ind":"1.43"},{"date":"2026.03.23","stock":"-6.12","trade":null,"ind":"-3.76"},{"date":"2026.03.20","stock":"-3.48","trade":null,"ind":"-0.25"},{"date":"2026.03.19","stock":"-2.37","trade":null,"ind":"-2.02"},{"date":"2026.03.18","stock":"2.27","trade":null,"ind":"1.05"},{"date":"2026.03.17","stock":"-0.90","trade":null,"ind":"-1.87"},{"date":"2026.03.16","stock":"0.60","trade":null,"ind":"0.19"},{"date":"2026.03.13","stock":"0.30","trade":null,"ind":"-0.65"},{"date":"2026.03.12","stock":"-0.60","trade":null,"ind":"-0.63"},{"date":"2026.03.11","stock":"-1.34","trade":null,"ind":"0.78"},{"date":"2026.03.10","stock":"1.81","trade":null,"ind":"2.04"},{"date":"2026.03.09","stock":"0.46","trade":null,"ind":"-0.74"},{"date":"2026.03.06","stock":"2.81","trade":null,"ind":"0.59"},{"date":"2026.03.05","stock":"1.91","trade":null,"ind":"1.23"},{"date":"2026.03.04","stock":"0.32","trade":null,"ind":"-0.75"},{"date":"2026.03.03","stock":"-4.13","trade":null,"ind":"-3.07"},{"date":"2026.03.02","stock":"-3.25","trade":null,"ind":"-0.20"},{"date":"2026.02.27","stock":"0.15","trade":null,"ind":"-0.06"},{"date":"2026.02.26","stock":"-1.46","trade":null,"ind":"0.19"},{"date":"2026.02.25","stock":"0.29","trade":null,"ind":"1.29"},{"date":"2026.02.24","stock":"0.44","trade":null,"ind":"1.36"}]
凯普生物,深证成指,医疗器械指数
压力支撑
该股压力位为6.14元，支撑位为5.97元。
[{"text":"\u538b\u529b\u4f4d","value":"6.14","date":1774281600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.97","date":1774281600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.9资金面打败了36%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：03月24日 20:30
| 机构今日流向(万元) | 791.19 | 机构5日流向(万元) | -2652.84 |
| 机构10日流向(万元) | -4808.44 | 机构20日流向(万元) | -9644.86 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少28237.27万股，其中基金数没有增加，主力净减仓50家，请投资者中长期谨慎为宜。
截止2025-12-31，共1家主力机构（基金1家），持仓量总计21.53万股，占流通A股0.03%
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有21.53万股
从主力名单中消失：51家 ，原持有28258.8万股
其中，基金持仓与2025-06-30相比：
增仓：0家 ，增持 0万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有21.53万股
从主力名单中消失：51家 ，原持有28258.8万股
消息面诊股
诊断结果：6消息面打败了82%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 凯普生物：3月19日获融资买入1639.94万元
2026-03-20 - 凯普生物：3月18日获融资买入877.37万元
2026-03-19 - 凯普生物：拟使用不超过8.00亿元闲置自有资金进行
2026-03-18 - 凯普生物：3月17日获融资买入722.32万元
2026-03-18 - 凯普生物：公司与您提及的泓博医药暂无相关合作
2026-03-17 - 凯普生物（截止2026年3月10日）股东人数为41
2026-03-17 - 凯普生物：当2030年计划目标基本实现后，HPV检
2026-03-17 - 凯普生物：3月16日获融资买入1096.14万元
2026-03-17 - 凯普生物：3月13日获融资买入907.21万元
2026-03-16 - 全国最大HPV多中心流行病学研究登顶双一区TOP！
2026-03-13
消息列表
| 一般消息 | 募资投向 | 2026-03-18 | |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-06 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-04-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.03.24","price":"1.43","value":null},{"date":"2026.03.23","price":"-3.76","value":null},{"date":"2026.03.20","price":"-0.25","value":null},{"date":"2026.03.19","price":"-2.02","value":null},{"date":"2026.03.18","price":"1.05","value":null},{"date":"2026.03.17","price":"-1.87","value":null},{"date":"2026.03.16","price":"0.19","value":null},{"date":"2026.03.13","price":"-0.65","value":null},{"date":"2026.03.12","price":"-0.63","value":null},{"date":"2026.03.11","price":"0.78","value":null},{"date":"2026.03.10","price":"2.04","value":null},{"date":"2026.03.09","price":"-0.74","value":null},{"date":"2026.03.06","price":"0.59","value":null},{"date":"2026.03.05","price":"1.23","value":null},{"date":"2026.03.04","price":"-0.75","value":null},{"date":"2026.03.03","price":"-3.07","value":null},{"date":"2026.03.02","price":"-0.20","value":null},{"date":"2026.02.27","price":"-0.06","value":null},{"date":"2026.02.26","price":"0.19","value":null},{"date":"2026.02.25","price":"1.29","value":null},{"date":"2026.02.24","price":"1.36","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 英科医疗 | 37.18% | -7.32% | 5.0分 |
| 2 | 九安医疗 | 36.53% | 11.65% | 5.5分 |
| 3 | 蓝帆医疗 | 33.11% | -1.88% | 5.3分 |
| 4 | 中源协和 | 20.35% | 4.70% | 4.9分 |
| 5 | 康拓医疗 | 16.74% | 6.89% | 6.2分 |
| 6 | 亚辉龙 | 10.40% | -1.24% | 4.6分 |
| 8 | 华兰股份 | 9.29% | -0.02% | 5.0分 |
| 10 | 中红医疗 | 8.16% | -15.44% | 4.9分 |
| 12 | 康众医疗 | 4.42% | -4.17% | 4.5分 |
| 14 | 爱迪特 | 3.73% | -1.06% | 4.5分 |
| 16 | 可孚医疗 | 1.18% | -6.52% | 5.5分 |
| 18 | 三鑫医疗 | 0.75% | -4.08% | 4.9分 |
| 20 | 维力医疗 | -0.20% | -0.92% | 6.1分 |
| 22 | 英诺特 | -0.95% | -6.30% | 4.7分 |
| 24 | 惠泰医疗 | -1.88% | -5.59% | 5.7分 |
| 26 | 国发股份 | -2.69% | 7.62% | 5.2分 |
| 28 | 采纳股份 | -3.42% | -2.21% | 4.5分 |
| 30 | 新产业 | -4.32% | -4.18% | 5.0分 |
| 32 | 威高骨科 | -5.09% | -11.63% | 5.1分 |
| 34 | 安旭生物 | -5.99% | -5.56% | 4.4分 |
| 36 | 理邦仪器 | -6.11% | -5.66% | 5.9分 |
| 38 | 北芯生命 | -6.48% | -9.10% | 5.0分 |
| 40 | 科华生物 | -6.79% | -3.51% | 4.3分 |
| 42 | 美康生物 | -7.12% | -7.02% | 4.4分 |
| 44 | 达安基因 | -7.39% | -4.38% | 5.2分 |
| 46 | 凯普生物 | -7.61% | -4.54% | 4.3分 |
| 48 | 正海生物 | -7.90% | -5.62% | 4.3分 |
| 50 | 欧普康视 | -8.18% | -9.18% | 4.6分 |
| 52 | 明德生物 | -8.38% | -7.45% | 4.4分 |
| 54 | 安图生物 | -8.68% | -5.42% | 5.2分 |
| 56 | 东方生物 | -8.75% | -2.16% | 4.9分 |
| 58 | 万东医疗 | -8.93% | -5.99% | 5.1分 |
| 60 | 威高血净 | -9.13% | -7.04% | 5.6分 |
| 62 | 赛诺医疗 | -9.32% | -6.46% | 4.9分 |
| 64 | - | -9.59% | -12.24% | 分 |
| 66 | 仁度生物 | -9.66% | -3.73% | 5.6分 |
| 68 | 正川股份 | -10.07% | -6.33% | 4.8分 |
| 70 | 之江生物 | -10.17% | -3.57% | 4.1分 |
| 72 | 开立医疗 | -10.26% | -7.19% | 4.3分 |
| 74 | 拱东医疗 | -10.38% | -4.87% | 5.3分 |
| 76 | 奥精医疗 | -10.40% | -7.86% | 5.5分 |
| 78 | 海利生物 | -10.46% | -7.87% | 3.9分 |
| 80 | 康德莱 | -10.64% | -7.49% | 5.3分 |
| 82 | 浩欧博 | -10.71% | -12.33% | 5.2分 |
| 84 | 南微医学 | -10.90% | -3.12% | 5.6分 |
| 86 | 普门科技 | -11.23% | -7.01% | 5.0分 |
| 88 | - | -11.47% | -3.55% | 分 |
| 90 | 安杰思 | -11.74% | -7.46% | 4.9分 |
| 92 | 济高发展 | -12.14% | -8.71% | 4.1分 |
| 94 | 康泰医学 | -12.31% | -6.79% | 4.7分 |
| 96 | 戴维医疗 | -12.41% | -6.55% | 6.1分 |
| 98 | 大博医疗 | -12.99% | -6.77% | 4.6分 |
| 100 | 三诺生物 | -13.19% | -7.03% | 5.0分 |
| 102 | 睿昂基因 | -13.65% | -6.88% | 4.1分 |
| 104 | 硕世生物 | -13.74% | -7.54% | 4.2分 |
| 106 | 易瑞生物 | -14.07% | -8.06% | 4.6分 |
| 108 | 西山科技 | -14.17% | -6.18% | 5.1分 |
| 110 | 翔宇医疗 | -14.74% | -12.29% | 4.8分 |
| 112 | 春立医疗 | -15.36% | -4.87% | 5.8分 |
| 114 | 爱博医疗 | -15.53% | -8.01% | 5.4分 |
| 116 | 爱朋医疗 | -15.60% | -13.05% | 3.9分 |
| 118 | 安必平 | -15.81% | -8.05% | 4.6分 |
| 120 | 楚天科技 | -16.12% | -9.44% | 4.6分 |
| 122 | 港通医疗 | -16.72% | -6.10% | 4.4分 |
| 124 | - | -17.07% | -9.80% | 分 |
| 126 | 山外山 | -17.42% | -4.87% | 5.5分 |
| 128 | - | -17.63% | -13.76% | 分 |
| 130 | - | -18.12% | -9.70% | 分 |
| 132 | 热景生物 | -18.83% | -12.98% | 3.5分 |
| 134 | 康为世纪 | -20.24% | -8.58% | 4.0分 |
| 136 | 华大智造 | -22.64% | -6.12% | 5.2分 |
| 138 | - | -24.81% | -12.15% | 分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 117/243 ， 80/243。
[{"date":"2025-09-30","value":"-3.21","vol":"2.98"},{"date":"2025-06-30","value":"-2.24","vol":"2.34"},{"date":"2025-03-31","value":"-0.67","vol":"1.16"},{"date":"2024-12-31","value":"-14.60","vol":"0.56"},{"date":"2024-09-30","value":"-5.60","vol":"4.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-3.21 | -2.24 | -0.67 | -14.60 | -5.60 |
| 行业(%) | 2.98 | 2.34 | 1.16 | 0.56 | 4.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"47.56","vol":"51.74"},{"date":"2025-06-30","value":"46.98","vol":"52.05"},{"date":"2025-03-31","value":"48.55","vol":"51.42"},{"date":"2024-12-31","value":"47.68","vol":"52.52"},{"date":"2024-09-30","value":"53.81","vol":"53.36"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.56 | 46.98 | 48.55 | 47.68 | 53.81 |
| 行业(%) | 51.74 | 52.05 | 51.42 | 52.52 | 53.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 114/243 ， 18/243。
[{"date":"2025-09-30","value":"-20.38","vol":"0.26"},{"date":"2025-06-30","value":"-22.96","vol":"-1.09"},{"date":"2025-03-31","value":"-26.78","vol":"-0.12"},{"date":"2024-12-31","value":"-26.16","vol":"1.15"},{"date":"2024-09-30","value":"-28.26","vol":"0.77"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-20.38 | -22.96 | -26.78 | -26.16 | -28.26 |
| 行业(%) | 0.26 | -1.09 | -0.12 | 1.15 | 0.77 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"51.25","vol":"-15.37"},{"date":"2025-06-30","value":"-16.46","vol":"-18.14"},{"date":"2025-03-31","value":"-90.21","vol":"-2.59"},{"date":"2024-12-31","value":"-566.20","vol":"-23.09"},{"date":"2024-09-30","value":"-252.19","vol":"-19.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
51.25 | -16.46 | -90.21 | -566.20 | -252.19 |
| 行业(%) | -15.37 | -18.14 | -2.59 | -23.09 | -19.92 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 114/243 ， 8/243。
[{"date":"2025-09-30","value":"0.11","vol":"0.25"},{"date":"2025-06-30","value":"0.07","vol":"0.17"},{"date":"2025-03-31","value":"0.03","vol":"0.08"},{"date":"2024-12-31","value":"0.16","vol":"0.36"},{"date":"2024-09-30","value":"0.11","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.07 | 0.03 | 0.16 | 0.11 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.36 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.51","vol":"1.66"},{"date":"2025-06-30","value":"2.33","vol":"1.12"},{"date":"2025-03-31","value":"1.00","vol":"0.55"},{"date":"2024-12-31","value":"5.17","vol":"2.32"},{"date":"2024-09-30","value":"3.01","vol":"1.64"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
3.51 | 2.33 | 1.00 | 5.17 | 3.01 |
| 行业(次) | 1.66 | 1.12 | 0.55 | 2.32 | 1.64 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"38.51","vol":"14.74"},{"date":"2025-06-30","value":"4.69","vol":"15.17"},{"date":"2025-03-31","value":"35.00","vol":"4.22"},{"date":"2024-12-31","value":"16.75","vol":"29.38"},{"date":"2024-09-30","value":"38.54","vol":"15.46"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 38.51 | 4.69 | 35.00 | 16.75 | 38.54 |
| 行业 | 14.74 | 15.17 | 4.22 | 29.38 | 15.46 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.36","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.75","vol":"2.17"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.36 | - | 0.75 | - |
| 行业 | 0.01 | 1.57 | 0.00 | 2.17 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 78/243 ， 87/243。
[{"date":"2025-09-30","value":"5.06","vol":"5.66"},{"date":"2025-06-30","value":"4.99","vol":"5.47"},{"date":"2025-03-31","value":"5.19","vol":"5.84"},{"date":"2024-12-31","value":"5.04","vol":"5.30"},{"date":"2024-09-30","value":"6.55","vol":"5.83"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.06 | 4.99 | 5.19 | 5.04 | 6.55 |
| 行业 | 5.66 | 5.47 | 5.84 | 5.30 | 5.83 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"4.65","vol":"4.51"},{"date":"2025-06-30","value":"4.59","vol":"4.35"},{"date":"2025-03-31","value":"4.12","vol":"4.73"},{"date":"2024-12-31","value":"4.13","vol":"4.27"},{"date":"2024-09-30","value":"6.03","vol":"4.70"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.65 | 4.59 | 4.12 | 4.13 | 6.03 |
| 行业 | 4.51 | 4.35 | 4.73 | 4.27 | 4.70 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 91/243 ， 96/243。
[{"date":"2025-09-30","value":"12.93","vol":"22.07"},{"date":"2025-06-30","value":"13.28","vol":"22.01"},{"date":"2025-03-31","value":"13.12","vol":"21.19"},{"date":"2024-12-31","value":"12.47","vol":"21.94"},{"date":"2024-09-30","value":"10.04","vol":"20.60"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
12.93 | 13.28 | 13.12 | 12.47 | 10.04 |
| 行业(%) | 22.07 | 22.01 | 21.19 | 21.94 | 20.60 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.14","vol":"0.71"},{"date":"2025-06-30","value":"0.15","vol":"0.58"},{"date":"2025-03-31","value":"0.15","vol":"0.56"},{"date":"2024-12-31","value":"0.14","vol":"0.55"},{"date":"2024-09-30","value":"0.11","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.14 | 0.15 | 0.15 | 0.14 | 0.11 |
| 行业(%) | 0.71 | 0.58 | 0.56 | 0.55 | 0.37 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"8.52","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"17.26","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-6.55","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]